{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:08:25Z","timestamp":1790399305751,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T00:00:00Z","timestamp":1291075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"},{"start":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T00:00:00Z","timestamp":1291075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms1129","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T11:32:47Z","timestamp":1291116767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Substrate docking to \u03b3-secretase allows access of \u03b3-secretase modulators to an allosteric site"],"prefix":"10.1038","volume":"1","author":[{"given":"Kengo","family":"Uemura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C.","family":"Farner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadafumi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navine","family":"Nasser-Ghodsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward H.","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley T.","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Berezovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,30]]},"reference":[{"key":"BFncomms1129_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/34910","volume":"391","author":"B De Strooper","year":"1998","unstructured":"De Strooper, B. et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387\u2013390 (1998).","journal-title":"Nature"},{"key":"BFncomms1129_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"MS Wolfe","year":"1999","unstructured":"Wolfe, M. S. et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398, 513\u2013517 (1999).","journal-title":"Nature"},{"key":"BFncomms1129_CR3","doi-asserted-by":"publisher","first-page":"34882","DOI":"10.1074\/jbc.M300825200","volume":"278","author":"G Bitan","year":"2003","unstructured":"Bitan, G., Vollers, S. S. & Teplow, D. B. Elucidation of primary structure elements controlling early amyloid \u03b2-protein oligomerization. J. Biol. Chem. 278, 34882\u201334889 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFncomms1129_CR4","doi-asserted-by":"publisher","first-page":"24414","DOI":"10.1074\/jbc.M602363200","volume":"281","author":"YR Chen","year":"2006","unstructured":"Chen, Y. R. & Glabe, C. G. Distinct early folding and aggregation properties of Alzheimer amyloid-\u03b2 peptides A\u03b240 and A\u03b242: stable trimer or tetramer formation by A\u03b242. J. Biol. Chem. 281, 24414\u201324422 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFncomms1129_CR5","doi-asserted-by":"publisher","first-page":"31831","DOI":"10.1074\/jbc.M303592200","volume":"278","author":"S Weggen","year":"2003","unstructured":"Weggen, S. et al. Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid \u03b242 production by direct modulation of gamma-secretase activity. J. Biol. Chem. 278, 31831\u201331837 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFncomms1129_CR6","doi-asserted-by":"publisher","first-page":"43419","DOI":"10.1074\/jbc.M404937200","volume":"279","author":"D Beher","year":"2004","unstructured":"Beher, D. et al. Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma-secretase at a novel site. Evidence for an allosteric mechanism. J. Biol. Chem. 279, 43419\u201343426 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFncomms1129_CR7","doi-asserted-by":"publisher","first-page":"20228","DOI":"10.1073\/pnas.0910757106","volume":"106","author":"CC Shelton","year":"2009","unstructured":"Shelton, C. C. et al. Modulation of gamma-secretase specificity using small molecule allosteric inhibitors. Proc. Natl Acad. Sci. USA 106, 20228\u201320233 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms1129_CR8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nature07055","volume":"453","author":"TL Kukar","year":"2008","unstructured":"Kukar, T. L. et al. Substrate-targeting gamma-secretase modulators. Nature 453, 925\u2013929 (2008).","journal-title":"Nature"},{"key":"BFncomms1129_CR9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm1112","volume":"10","author":"A Lle\u00f3","year":"2004","unstructured":"Lle\u00f3, A. et al. Nonsteroidal anti-inflammatory drugs lower A\u03b242 and change presenilin 1 conformation. Nat. Med. 10, 1065\u20131066 (2004).","journal-title":"Nat. Med."},{"key":"BFncomms1129_CR10","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1523\/JNEUROSCI.0364-05.2005","volume":"25","author":"O Berezovska","year":"2005","unstructured":"Berezovska, O. et al. Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein. J. Neurosci. 25, 3009\u20133017 (2005).","journal-title":"J. Neurosci."},{"key":"BFncomms1129_CR11","doi-asserted-by":"publisher","first-page":"e7893","DOI":"10.1371\/journal.pone.0007893","volume":"4","author":"K Uemura","year":"2009","unstructured":"Uemura, K. et al. Allosteric modulation of PS1\/gamma-secretase conformation correlates with amyloid \u03b2(42\/40) ratio. PLoS One 4, e7893 (2009).","journal-title":"PLoS One"},{"key":"BFncomms1129_CR12","doi-asserted-by":"publisher","first-page":"11794","DOI":"10.1021\/ja037131v","volume":"125","author":"C Das","year":"2003","unstructured":"Das, C. et al. Designed helical peptides inhibit an intramembrane protease. J. Am. Chem. Soc. 125, 11794\u201311795 (2003).","journal-title":"J. Am. Chem. Soc."},{"key":"BFncomms1129_CR13","doi-asserted-by":"publisher","first-page":"12388","DOI":"10.1074\/jbc.M611549200","volume":"282","author":"N Isoo","year":"2007","unstructured":"Isoo, N. et al. A\u03b242 overproduction associated with structural changes in the catalytic pore of gamma-secretase: common effects of Pen-2 N-terminal elongation and fenofibrate. J. Biol. Chem. 282, 12388\u201312396 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFncomms1129_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0896-6273(01)00512-8","volume":"32","author":"WG Annaert","year":"2001","unstructured":"Annaert, W. G. et al. Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 32, 579\u2013589 (2001).","journal-title":"Neuron"},{"key":"BFncomms1129_CR15","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1073\/pnas.0407640102","volume":"102","author":"AY Kornilova","year":"2005","unstructured":"Kornilova, A. Y., Bihel, F., Das, C. & Wolfe, M. S. The initial substrate-binding site of gamma-secretase is located on presenilin near the active site. Proc. Natl Acad. Sci. USA 102, 3230\u20133235 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms1129_CR16","doi-asserted-by":"publisher","first-page":"12081","DOI":"10.1523\/JNEUROSCI.3614-06.2006","volume":"26","author":"C Sato","year":"2006","unstructured":"Sato, C., Morohashi, Y., Tomita, T. & Iwatsubo, T. Structure of the catalytic pore of gamma-secretase probed by the accessibility of substituted cysteines. J. Neurosci. 26, 12081\u201312088 (2006).","journal-title":"J. Neurosci."},{"key":"BFncomms1129_CR17","doi-asserted-by":"crossref","first-page":"17386","DOI":"10.1016\/S0021-9258(17)32449-3","volume":"269","author":"EH Koo","year":"1994","unstructured":"Koo, E. H. & Squazzo, S. L. Evidence that production and release of amyloid \u03b2-protein involves the endocytic pathway. J. Biol. Chem. 269, 17386\u201317389 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFncomms1129_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/35102591","volume":"414","author":"S Weggen","year":"2001","unstructured":"Weggen, S. et al. A subset of NSAIDs lower amyloidogenic A\u03b242 independently of cyclooxygenase activity. Nature 414, 212\u2013216 (2001).","journal-title":"Nature"},{"key":"BFncomms1129_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nm1235","volume":"11","author":"T Kukar","year":"2005","unstructured":"Kukar, T. et al. Diverse compounds mimic Alzheimer disease-causing mutations by augmenting A\u03b242 production. Nat. Med. 11, 545\u2013550 (2005).","journal-title":"Nat. Med."},{"key":"BFncomms1129_CR20","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/emboj\/21.7.1524","volume":"21","author":"T Hashimoto","year":"2002","unstructured":"Hashimoto, T. et al. CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P\/collagen type XXV. EMBO J 21, 1524\u20131534 (2002).","journal-title":"EMBO J"},{"key":"BFncomms1129_CR21","doi-asserted-by":"publisher","first-page":"14597","DOI":"10.1073\/pnas.1003026107","volume":"107","author":"L Richter","year":"2010","unstructured":"Richter, L. et al. Amyloid \u03b242 peptide A\u03b242-lowering compounds directly bind to A\u03b2 and interfere with amyloid precursor protein (APP) transmembrane dimerization. Proc. Natl Acad. Sci. USA 107, 14597\u201314602 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms1129_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.mcn.2009.02.008","volume":"41","author":"L Herl","year":"2009","unstructured":"Herl, L. et al. Mutations in amyloid precursor protein affect its interactions with presenilin\/gamma-secretase. Mol. Cell Neurosci. 41, 166\u2013174 (2009).","journal-title":"Mol. Cell Neurosci."},{"key":"BFncomms1129_CR23","doi-asserted-by":"publisher","first-page":"17798","DOI":"10.1074\/jbc.M110.103283","volume":"285","author":"RM Page","year":"2010","unstructured":"Page, R. M. et al. APP mutants respond to gamma-secretase modulators. J. Biol. Chem. 285, 17798\u201317810 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFncomms1129_CR24","doi-asserted-by":"publisher","first-page":"11837","DOI":"10.1021\/bi901839d","volume":"48","author":"AJ Beel","year":"2009","unstructured":"Beel, A. J. et al. Nonspecificity of binding of gamma-secretase modulators to the amyloid precursor protein. Biochemistry 48, 11837\u201311839 (2009).","journal-title":"Biochemistry"},{"key":"BFncomms1129_CR25","doi-asserted-by":"publisher","first-page":"24504","DOI":"10.1074\/jbc.M700618200","volume":"282","author":"E Czirr","year":"2007","unstructured":"Czirr, E. et al. Insensitivity to A\u03b242-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations. J. Biol. Chem. 282, 24504\u201324513 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFncomms1129_CR26","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1073\/pnas.052436599","volume":"99","author":"WP Esler","year":"2002","unstructured":"Esler, W. P. et al. Activity-dependent isolation of the presenilin- gamma -secretase complex reveals nicastrin and a gamma substrate. Proc. Natl Acad. Sci. USA 99, 2720\u20132725 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms1129_CR27","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1021\/bi0005456","volume":"39","author":"MS Shearman","year":"2000","unstructured":"Shearman, M. S. et al. L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid \u03b2-protein precursor gamma-secretase activity. Biochemistry 39, 8698\u20138704 (2000).","journal-title":"Biochemistry"},{"key":"BFncomms1129_CR28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0014-5793(99)00730-9","volume":"453","author":"SF Lichtenthaler","year":"1999","unstructured":"Lichtenthaler, S. F., Multhaup, G., Masters, C. L. & Beyreuther, K. A novel substrate for analyzing Alzheimer's disease gamma-secretase. FEBS Lett. 453, 288\u2013292 (1999).","journal-title":"FEBS Lett."},{"key":"BFncomms1129_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S1097-2765(00)80416-5","volume":"5","author":"JS Mumm","year":"2000","unstructured":"Mumm, J. S. et al. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol. Cell 5, 197\u2013206 (2000).","journal-title":"Mol. Cell"},{"key":"BFncomms1129_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1046\/j.1471-4159.2002.01016.x","volume":"82","author":"A Kinoshita","year":"2002","unstructured":"Kinoshita, A., Whelan, C. M., Smith, C. J., Berezovska, O. & Hyman, B. T. Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus. J. Neurochem. 82, 839\u2013847 (2002).","journal-title":"J. Neurochem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms1129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms1129","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms1129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T04:04:48Z","timestamp":1672977888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms1129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,30]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,12,21]]}},"alternative-id":["BFncomms1129"],"URL":"https:\/\/doi.org\/10.1038\/ncomms1129","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,30]]},"assertion":[{"value":"27 August 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}